BACKGROUND
Finerenone, a non-steroidal mineralocorticoid receptor antagonist, improves cardiorenal outcomes in patients with type 2 diabetes mellitus and chronic kidney disease. However, real-world data on its use in patients with concomitant heart failure remain limited. This study aimed to evaluate the baseline chara...
Serap Yadigar, Suat Akgür, T. Güvenç et al.· Cardiovascular Drugs and The...· 0 citations
Objective: Silent brain lesions (SBL), including silent brain infarction (SBI) and subcortical white matter lesions (SWML), are increasingly recognized as important radiological markers of cerebral small vessel disease. Patients with chronic kidney disease (CKD) may be at increased risk due to shared vascular and metab...
I. Baloglu, Yasin Öztürk, Cemile Feyza Elbistan et al.· Turkish Journal of Internal...· 0 citations
BACKGROUND
Dickkopf-3 (DKK3) is a stress-induced glycoprotein involved in Wnt/β-catenin signaling and has emerged as a marker of renal tubular injury and fibrosis. Although urinary DKK3 has been associated with kidney disease progression independent of albuminuria, its relationship with vascular dysfunction in diabetic...
Merve Oruç, I. Baloglu, Mehmet Burak Erçin et al.· Clinical Nephrology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.